Form 13-F position report

COGNITION THERAPEUTICS INC

Reported by MORGAN STANLEY

Company profile Manager portfolio Source filing
CGTX CUSIP 19243B102 Manager CIK 0000895421
Latest reported change

Reported 21,869 shares, unchanged from the prior quarter.

Reported value -7.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q2 2023
Shares 21,869 Quarter-end amount reported
Reported value $40,020 Fair value at quarter end
Consecutive quarters held 5 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

17 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q2 2026 Unchanged 27,873 0 (0.0%) < 0.01% $32,054 2026-08-13
Q1 2026 Reduced 27,873 -65,455 (-70.1%) < 0.01% $21,170 2026-05-15
Q4 2025 Added 93,328 +60,638 (185.5%) < 0.01% $125,993 2026-02-13
Q3 2025 Added 32,690 +1,621 (5.2%) < 0.01% $44,132 2025-11-14
Q2 2025 Unchanged 31,069 0 (0.0%) < 0.01% $9,625 2025-08-15
Q1 2025 Added 31,069 +14,196 (84.1%) < 0.01% $13,074 2025-05-15
Q4 2024 Added 16,873 +15,873 (1587.3%) < 0.01% $11,833 2025-02-14
Q3 2024 Reduced 1,000 -2,000 (-66.7%) < 0.01% $469 2024-11-14
Q2 2024 Unchanged 3,000 0 (0.0%) < 0.01% $4,980 2024-08-14
Q1 2024 Reduced 3,000 -18,869 (-86.3%) < 0.01% $5,460 2024-05-15
Q4 2023 Unchanged 21,869 0 (0.0%) < 0.01% $40,458 2024-02-13
Q3 2023 Unchanged 21,869 0 (0.0%) < 0.01% $31,491 2023-11-15
Q2 2023 Unchanged 21,869 0 (0.0%) < 0.01% $40,020 2023-08-14
Q1 2023 Unchanged 21,869 0 (0.0%) < 0.01% $43,301 2023-05-15
Q4 2022 Unchanged 21,869 0 (0.0%) < 0.01% $45,925 2023-02-14
Q3 2022 Unchanged 21,869 0 (0.0%) < 0.01% $42,000 2022-11-14
Q2 2022 New 21,869 +21,869 (0.0%) < 0.01% $46,000 2022-08-15
Institutional context

Who else reported the position

39 managers reported COGNITION THERAPEUTICS INC for Q2 2023.

Manager Activity Shares Change % of reported 13F Reported value Tenure
PATHSTONE FAMILY OFFICE LLC Reduced 2,205,377 -5,000 0.06% $4,035,840 5 qtrs
AIGH Capital Management LLC Added 2,038,853 +1,000 1.52% $3,731,101 7 qtrs
VANGUARD GROUP INC Added 668,425 +25,035 < 0.01% $1,223,218 7 qtrs
Worth Venture Partners LLC Added 508,719 +7,000 0.51% $930,956 6 qtrs
CARLSON CAPITAL L P Reduced 245,000 -169 0.04% $448,350 4 qtrs
Perigon Wealth Management LLC Reduced 223,500 -1,500 0.02% $409,005 5 qtrs
AMERICAN FINANCIAL GROUP INC Unchanged 205,000 0 0.12% $375,000 7 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 176,498 +53,900 < 0.01% $322,991 6 qtrs
Kestra Advisory Services LLC Added 173,784 +78,784 < 0.01% $318,025 7 qtrs
COMMONWEALTH EQUITY SERVICES LLC Reduced 93,235 -75,457 < 0.01% $171,000 6 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
21,869

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.